MERCK’S CAPVAXIVE™ (PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE) DEMONSTRATES POSITIVE IMMUNE RESPONSES IN ADULTS WITH INCREASED RISK FOR PNEUMOCOCCAL DISEASE

Reuters · 10/16 10:45

Please log in to view news